[Source: Bioarray News, Justin Petrone] – Applied Microarrays and Expression Analysis last week separately announced plans to expand the scope of their respective businesses in response to what they said is increased desire from pharmaceutical and biotechnology companies to outsource their array production and array-based research projects.
Tempe, Ariz.-based AMI, which in 2007 bought all of GE Healthcare’s Codelink bioarray assets other than its slide chemistry, has already hired additional scientists and logistics personnel and this year plans to expand its manufacturing space and add additional OEM capabilities (see BAN 5/8/2007).
For more information click here.